Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

ClinicalTrials.gov ID: NCT03118947

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03118947. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 6:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week Open-Label Extension Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and tolerability of pimavanserin over 52 weeks of treatment in subjects with probable AD who have symptoms of agitation and aggression

Study identification

NCT ID
NCT03118947
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
79 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 23, 2017 (Actual)
Primary completion
Feb 25, 2019 (Actual)
Completion
Feb 25, 2019 (Actual)
Last update posted
Apr 9, 2020

2017 – 2019

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
ATP Clinical Research, Inc. Costa Mesa California 92626 —
Neuro-Pain Medical Center Fresno California 93710 —
Neurology Center of North Orange County Fullerton California 92835 —
Pacific Clinical Research Network San Diego California 92103 —
Clinical Research Unit Washington D.C. District of Columbia 20007 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
Quantum Laboratories Inc. Deerfield Beach Florida 33064 —
Miami Jewish Health Systems Miami Florida 33137 —
Collier Neurologic Specialists LLC Naples Florida 34105 —
Acadia Hospital Bangor Maine 04401 —
Alzheimer's Disease Center Quincy Massachusetts 02169 —
Memory Enhancement Center of America, Inc. Eatontown New Jersey 07724 —
Bio Behavioral Health Toms River New Jersey 08755 —
ANI Neurology, PLLC dba Alzheimer's Memory Center Charlotte North Carolina 28270 —
Abington Neurological Associates, Ltd. Willow Grove Pennsylvania 19090 —
Insite Clinical Research, LLC DeSoto Texas 75115 —
Pharmaceutical Research Associates, Inc. Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03118947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2020 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.